Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease.

The propensity for developing atherosclerosis is dependent on underlying genetic risk and varies as a function of age and exposure to environmental risk factors. Employing three mouse models with different disease susceptibility, two diets, and a longitudinal experimental design, it was possible to manipulate each of these factors to focus analysis on genes most likely to have a specific disease-related function. To identify differences in longitudinal gene expression patterns of atherosclerosis, we have developed and employed a statistical algorithm that relies on generalized regression and permutation analysis. Comprehensive annotation of the array with ontology and pathway terms has allowed rigorous identification of molecular and biological processes that underlie disease pathophysiology. The repertoire of atherosclerosis-related immunomodulatory genes has been extended, and additional fundamental pathways have been identified. This highly disease-specific group of mouse genes was combined with an extensive human coronary artery data set to identify a shared group of genes differentially regulated among atherosclerotic tissues from different species and different vascular beds. A small core subset of these differentially regulated genes was sufficient to accurately classify various stages of the disease in mouse. The same gene subset was also found to accurately classify human coronary lesion severity. In addition, this classifier gene set was able to distinguish with high accuracy atherectomy specimens from native coronary artery disease vs. those collected from in-stent restenosis lesions, thus identifying molecular differences between these two processes. These studies significantly focus efforts aimed at identifying central gene regulatory pathways that mediate atherosclerotic disease, and the identification of classification gene sets offers unique insights into potential diagnostic and therapeutic strategies in atherosclerotic disease.

[1]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[2]  O. Ornatsky,et al.  Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[4]  R. Tibshirani,et al.  Mouse Strain–Specific Differences in Vascular Wall Gene Expression and Their Relationship to Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[5]  G. Ferns,et al.  Markers of inflammation and coronary artery disease. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[6]  T. Springer,et al.  Modulation of Endothelial Cell Adhesion by Hevin, an Acidic Protein Associated with High Endothelial Venules (*) , 1996, The Journal of Biological Chemistry.

[7]  Per Eriksson,et al.  Gene Expression in Atherosclerotic Lesion of ApoE Deficient Mice , 2001, Molecular medicine.

[8]  P. Cresswell,et al.  Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Napoli,et al.  Determination of atherogenesis in apolipoprotein E-knockout mice. , 2000, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[10]  A. Lusis,et al.  Atherosclerosis in C3H/HeJ Mice Reconstituted With Apolipoprotein E-Null Bone Marrow , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[11]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. Shum,et al.  TGF-beta 3 decreases type I collagen and scarring after labioplasty. , 2003, Journal of dental research.

[13]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. Li,et al.  Oncostatin M-Induced Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinase-3 Genes Expression in Chondrocytes Requires Janus Kinase/STAT Signaling Pathway1 , 2001, The Journal of Immunology.

[15]  B. Efron Large-Scale Simultaneous Hypothesis Testing , 2004 .

[16]  F. Neumann,et al.  Transcriptome Analysis Reveals a Role of Interferon-γ in Human Neointima Formation , 2001 .

[17]  P. Nastalek,et al.  Mouse models of experimental atherosclerosis. , 2004, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[18]  J. Soria,et al.  Oncostatin M induces procoagulant activity in human vascular smooth muscle cells by modulating the balance between tissue factor and tissue factor pathway inhibitor , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[19]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[20]  A. Roberts,et al.  TGF-beta is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells. Differential effects of TGF-beta 1 and TGF-beta 3. , 1993, Journal of immunology.

[21]  R. Tibshirani,et al.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Dawood B Dudekula,et al.  In situ-synthesized novel microarray optimized for mouse stem cell and early developmental expression profiling. , 2003, Genome research.

[23]  S. Schwartz,et al.  Expression Profiling Identifies 147 Genes Contributing to a Unique Primate Neointimal Smooth Muscle Cell Phenotype , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[24]  J. Neefs,et al.  Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation , 2000, British Journal of Cancer.

[25]  L. Shum,et al.  TGF-β3 Decreases Type I Collagen and Scarring after Labioplasty , 2003 .

[26]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[27]  J. C. BurgesChristopher A Tutorial on Support Vector Machines for Pattern Recognition , 1998 .

[28]  A. Liao,et al.  Transcriptional Profiling of the Heart Reveals Chamber-Specific Gene Expression Patterns , 2003, Circulation research.

[29]  Taesung Park,et al.  Statistical tests for identifying differentially expressed genes in time-course microarray experiments , 2003, Bioinform..

[30]  M. Cybulsky,et al.  High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. , 2000, The Journal of clinical investigation.

[31]  M. Daemen,et al.  Genes potentially involved in plaque rupture , 2002, Current opinion in lipidology.

[32]  U. Lerner,et al.  Calvariae B in Mouse κ and Receptor Activator of NFB Ligand , Osteoprotegerin , κ Activator of NF-Regulate the Expression of Receptor Oncostatin M Stimulate Bone Resorption and IL-6 , Leukemia Inhibitory Factor , and , 2002 .

[33]  R. Bonow,et al.  Atorvastatin Inhibits Hypercholesterolemia-Induced Cellular Proliferation and Bone Matrix Production in the Rabbit Aortic Valve , 2002, Circulation.

[34]  M. Downes,et al.  A Dynamic Role for HDAC7 in MEF2-mediated Muscle Differentiation* , 2001, The Journal of Biological Chemistry.

[35]  Shyamal D. Peddada,et al.  Gene Selection and Clustering for Time-course and Dose-response Microarray Experiments Using Order-restricted Inference , 2003, Bioinform..

[36]  Pascal J. Goldschmidt-Clermont,et al.  Aging, Progenitor Cell Exhaustion, and Atherosclerosis , 2003, Circulation.

[37]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[38]  W. Li,et al.  Signaling Pathway Chondrocytes Requires Janus Kinase / STAT Metalloproteinase-3 Genes Expression in Metalloproteinase and Tissue Inhibitor of Oncostatin M-Induced Matrix , 2001 .

[39]  W. Toyofuku,et al.  Atherosclerosis and plasma and liver lipids in nine inbred strains of mice , 1993, Lipids.

[40]  K. Sobue,et al.  Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation , 2004, Molecular and Cellular Biochemistry.

[41]  E. Topol,et al.  Identification of new genes differentially expressed in coronary artery disease by expression profiling. , 2003, Physiological genomics.

[42]  V. Rajagopal,et al.  Coronary restenosis: a review of mechanisms and management. , 2003, The American journal of medicine.

[43]  M. Glimcher,et al.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. , 2000, Science.

[44]  John D. Storey,et al.  Empirical Bayes Analysis of a Microarray Experiment , 2001 .

[45]  Magnus Ekström,et al.  Subsampling Methods to Estimate the Variance of Sample Means Based on Nonstationary Spatial Data With Varying Expected Values , 2004 .

[46]  Sayan Mukherjee,et al.  Molecular classification of multiple tumor types , 2001, ISMB.

[47]  N. Maeda,et al.  Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[48]  M. West,et al.  Gene Expression Phenotypes of Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[49]  木津 あかね Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators , 2005 .

[50]  H. Koyama,et al.  Induction of Bone-Type Alkaline Phosphatase in Human Vascular Smooth Muscle Cells: Roles of Tumor Necrosis Factor-&agr; and Oncostatin M Derived From Macrophages , 2002, Circulation research.

[51]  P. Ridker,et al.  Inflammatory bio‐markers and cardiovascular risk prediction , 2002, Journal of internal medicine.

[52]  R. Tibshirani,et al.  Empirical bayes methods and false discovery rates for microarrays , 2002, Genetic epidemiology.

[53]  T. Langmann,et al.  Identification of Sterol-independent Regulatory Elements in the Human ATP-binding Cassette Transporter A1 Promoter , 2002, The Journal of Biological Chemistry.

[54]  J. Breslow Mouse Models of Atherosclerosis , 1996, Science.

[55]  I. Adcock,et al.  A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Lennon,et al.  Identification of differentially expressed genes in coronary atherosclerotic plaques from patients with stable or unstable angina by cDNA array analysis , 2003, Journal of thrombosis and haemostasis : JTH.

[57]  T. Poggio,et al.  Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Russ B. Altman,et al.  Missing value estimation methods for DNA microarrays , 2001, Bioinform..

[59]  B. Paigen,et al.  Synthetic low and high fat diets for the study of atherosclerosis in the mouse. , 1990, Journal of lipid research.

[60]  S. Kyrylenko,et al.  Regulation of microglial inflammatory response by histone deacetylase inhibitors , 2003, Journal of neurochemistry.

[61]  Hongzhe Li,et al.  Clustering of time-course gene expression data using a mixed-effects model with B-splines , 2003, Bioinform..

[62]  Xiaochun Li,et al.  A Comparison of Parametric Versus Permutation Methods with Applications to General and Temporal Microarray Gene Expression Data , 2003, Bioinform..

[63]  J. Latcham,et al.  C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile. , 2000, Atherosclerosis.

[64]  I. Dusanter-Fourt,et al.  Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells : synergy with interleukin-1beta. , 1999, Circulation research.

[65]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[66]  Christopher J. C. Burges,et al.  A Tutorial on Support Vector Machines for Pattern Recognition , 1998, Data Mining and Knowledge Discovery.